Biogen wins Euro MS approval, but loses patents.

Brower, V

Biogen wins Euro MS approval, but loses patents. [electronic resource] - Nature biotechnology May 1997 - 410 p. digital

Publication Type: News

1087-0156

10.1038/nbt0597-410 doi


Adjuvants, Immunologic--therapeutic use
Biotechnology--economics
Drug Industry--economics
European Union
Glatiramer Acetate
Humans
Immunosuppressive Agents--therapeutic use
Interferon beta-1a
Interferon beta-1b
Interferon-beta--therapeutic use
Israel
Multiple Sclerosis--therapy
Patents as Topic--legislation & jurisprudence
Peptides--economics
Polymers
Recombinant Proteins--therapeutic use
United States